Cenegermin-bkbj 0.002 % Ophthamic Solution
RxNorm 2104336
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2104336 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: cenegermin-bkbj 0.002 % Ophthamic Solution.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
Cenegermin-bkbj 0.02 mg/ML Ophthalmic Solution
(Atom ID: 10779238)
PSNPrescribable
Prescribable Name (PSN):
Cenegermin-bkbj 0.002 % Ophthamic Solution
(Atom ID: 10779248)
SYPrescribable
Synonym (SY):
Cenegermin-bkbj 0.002 % Ophthamic Solution
(Atom ID: 10779247)
SYPrescribable
Synonym (SY):
Cenegermin-bkbj 20 mcg/ML Ophthamic Solution
(Atom ID: 10779250)
Patient Education
Cenegermin-bkbj Ophthalmic
Ophthalmic cenegermin-bkbj is used to treat neurotrophic keratitis (a degenerative eye disease that can lead to damage of the cornea [the outermost layer of the eye]). Cenegermin-bkbj is in a class of medications called recombinant human nerve growth factors. It works to heal the cornea.
[Learn More]
* Please review the disclaimer below.